Literature DB >> 1941622

Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus.

M Starec1, B Rouveix, M Sinet, F Chau, B Desforges, J J Pocidalo, P Lechat.   

Abstract

In as much as the immunomodulatory effects of opiates and cocaine are known to modify spontaneous host defenses against infection, we investigated the effects of morphine, pentazocine and cocaine on the time course of Friend virus infection in mice. Repeated i.p. injections with increasing doses of morphine hydrochloride (10-100 mg/kg for 10 days before infection, a dose regimen which induced tolerance to the acute antinociceptive effects of the drug, followed by 30 mg/kg for 14 days postinfection) did not increase the mortality due to Friend virus infection. This regimen did not significantly affect the immune response of infected mice assessed in terms of delayed hypersensitivity (ear thickness) and the hemagglutination assay. In contrast, a single challenge with a large dose of morphine (up to 300 mg/kg), which is not lethal in noninfected mice, increased mortality markedly (up to 100%) in infected mice when administered at day 14 or 21 postinfection. Repeated i.p. injections with pentazocine (50 mg/kg b.i.d. for 5 days before infection, followed by 30 mg/kg for 14 days postinfection) had no influence on mortality or immune responses in infected mice; similar results were obtained with a single high-dose injection (up to 100 mg/kg). Lastly, repeated i.p. injections of cocaine, using the same experimental procedure as that for pentazocine, decreased immune responsiveness and slightly increased mortality, whereas a single injection was devoid of lethal effect. These findings suggest that chronic opioid treatment does not lower host resistance to viral infection but that the latter could increase the toxicity of a single high dose of morphine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941622

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  Interactions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periaqueductal grey.

Authors:  Silke Heinisch; Jonathan Palma; Lynn G Kirby
Journal:  Brain Behav Immun       Date:  2010-10-23       Impact factor: 7.217

Review 3.  Drugs of abuse, immune modulation, and AIDS.

Authors:  Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-28       Impact factor: 4.147

Review 4.  Opioids and infections in the intensive care unit should clinicians and patients be concerned?

Authors:  Craig R Weinert; Shravan Kethireddy; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-05       Impact factor: 4.147

5.  The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women.

Authors:  Howard Minkoff; Ye Zhong; Howard D Strickler; D Heather Watts; Joel M Palefsky; Alexandra M Levine; Gypsyamber D'Souza; Andrea A Howard; Michael Plankey; L Stewart Massad; Robert Burk
Journal:  Infect Dis Obstet Gynecol       Date:  2008

6.  Psychoimmunology and infection.

Authors:  Thomas W Klein
Journal:  Clin Microbiol Newsl       Date:  2002-11-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.